Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

Cited by (226)

Items 101–200 of 226

1. Design and analysis of three‐arm trials with negative binomially distributed endpoints
   Tobias Mütze, Axel Munk, Tim Friede · 2015 · Statistics in Medicine
2. Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure
   Enrique Santas, Rafael de la Espriella, Anna Mollar, Ernesto Valero, Gema Miñana, Juan Manuel Sanchís, F. Javier Chorro, Julio E. Núñez · 2017 · International Journal of Cardiology
3. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction
   Gema Miñana, Rafael de la Espriella, Patricia Palau, Pau Llàcer, Eduardo Núñez, Enrique Santas, Ernesto Valero, Miguel Lorenzo, Gonzalo Núñez, Vicente Bodı́ et al. · 2022 · Scientific Reports
4. Visualising harms in publications of randomised controlled trials: consensus and recommendations
   Rachel Phillips, Suzie Cro, Graham Wheeler, Simon James Bond, Tim Peter Morris, Siobhan Creanor, Catherine Elizabeth Hewitt, Sharon Love, Andre Lopes, Iryna Schlackow et al. · 2022 · BMJ
5. Rehospitalization Burden and Morbidity Risk in Patients with Heart Failure with Mid-Range Ejection Fraction
   Enrique Santas, Rafael de la Espriella, Patricia Palau, Gema Miñana, Martina Amiguet, Juan Manuel Sanchís, Josep Lupón, Antoni Bayés‐Genís, F. Javier Chorro, Julio Núñez Villota · 2020 · ESC Heart Failure
6. Endpoints in Heart Failure Drug Development
   Aliza Hussain, Arunima Misra, Biykem Bozkurt · 2022 · Cardiac failure review
7. Angiotensin-Converting Enzyme and Heart Failure
   Sara Álvarez-Zaballos, Manuel Martínez‐Sellés · 2023 · Frontiers in Bioscience-Landmark
8. The current best drug treatment for hypertensive heart failure with preserved ejection fraction
   Aurora Rist, Kaja Sevre, Kristian Wachtell, Richard B. Devereux, Gerard P. Aurigemma, Otto Armin Smiseth, Sverre Erik Kjeldsen, Stevo Julius, Bertram Pitt, Michel Burnier et al. · 2023 · European Journal of Internal Medicine
9. New Medicinal Products for Chronic Heart Failure: Advances in Clinical Trial Design and Efficacy Assessment
   Martín Cowie, Gerasimos S Filippatos, Maria de los Angeles Alonso García, Stefan D. Anker, Anna Baczyńska, Daniel M. Bloomfield, Maria Borentain, Karsten Bruins Slot, Maureen Cronin, Pieter A. Doevendans et al. · 2017 · European Journal of Heart Failure
10. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
    Scott D. Berkowitz, Rupert Martin Bauersachs, Michael J. Szarek, Mark R. Nehler, E. Sebastian Debus, Manesh R. Patel, Sonia Savitri Anand, Warren H. Capell, Connie Ng Hess, Judith A. Hsia et al. · 2022 · Journal of Thrombosis and Haemostasis
11. N-Terminal Pro–B-Type Natriuretic Peptide–Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations—Results From TIME-CHF
    Nasser Davarzani, Sandra Sanders‐van Wijk, Joel M. H. Karel, Micha Tobias Maeder, Gregor Leibundgut, Marc Gutmann, Matthias Emil Pfisterer, Peter R. Rickenbacher, Ralf Peeters, Hans‐Peter Brunner‐La Rocca · 2017 · Journal of Cardiac Failure
12. Employment Status at Time of First Hospitalization for Heart Failure is Associated with a Higher Risk of Death and Rehospitalization for Heart Failure
    Rasmus Rørth, Emil Loldrup Fosbøl, Ulrik Madvig Mogensen, Kristian Hay Kragholm, Anna‐Karin Numé, Gunnar Gislason, Pardeep S. Jhund, Mark Colquhoun Petrie, John J.V. McMurray, Christian Tobias Torp-Pedersen et al. · 2017 · European Journal of Heart Failure
13. Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions
    Marco Metra, Daniela Tomasoni, Marianna Adamo, Stefan D. Anker, Antoni Bayés‐Genís, Ralph Stephan von Bardeleben, Michael Böhm, Erwan Donal, Gerasimos S Filippatos, Francesco Maisano et al. · 2025 · Circulation
14. Properties of Two While-Alive Estimands for Recurrent Events and Their Potential Estimators
    Jiawei Wei, Tobias Mütze, Antje Jahn‐Eimermacher, James Roger · 2021 · Statistics in Biopharmaceutical Research
15. Group sequential designs for negative binomial outcomes
    Tobias Mütze, Ekkehard Glimm, Heinz Schmidli, Tim Friede · 2018 · Statistical Methods in Medical Research
16. Impact of Physical Activity on Dialysis and Nondialysis Days and Clinical Outcomes Among Patients on Hemodialysis
    Shohei Yamamoto, Ryota Matsuzawa, Keika Hoshi, Manae Harada, Takaaki Watanabe, Yuta Suzuki, Yusuke Isobe, Keigo Imamura, Shiwori Osada, Atsushi Yoshida et al. · 2020 · Journal of Renal Nutrition
17. Association between up‐titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum
    Vasiliki Bistola, Panagiotis Simitsis, John Parissis, Wouter Ouwerkerk, Dirk J. van Veldhuisen, John G.F. Cleland, Stefan D. Anker, Nilesh J. Samani, Marco Metra, Faiez M. Zannad et al. · 2021 · European Journal of Heart Failure
18. Re-Examination of the BEST Trial Using Composite Outcomes, Including Emergency Department Visits
    Li Shen, Pardeep S. Jhund, Ulrik Madvig Mogensen, Lars Køber, Brian Lee Claggett, Jennifer Kaye Rogers, John J.V. McMurray · 2017 · JACC Heart Failure
19. Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure
    Antoni Bayés‐Genís, Julio E. Núñez, Eduardo Núñez, Jaume Barallat, María Cruz Pastor Ferrer, Marta de Antonio, Elisabet Zamora, Juan Manuel Sanchís, Josep Lupón · 2016 · Frontiers in Cardiovascular Medicine
20. Pharmacological interventions for heart failure in people with chronic kidney disease
    Pietro Ravani, Robert Ross Quinn, Giovanni FM Strippoli · 2016 · Cochrane Database of Systematic Reviews
21. Hospitalization due to stroke and myocardial infarction in self-employed individuals and small business owners compared with paid employees in Sweden—a 5-year study
    Susanna Toivanen, Rosane Härter Griep, Christin Mellner, Mikael Nordenmark, Stig Vinberg, Sandra Eloranta · 2018 · Small Business Economics
22. Computational issues in fitting joint frailty models for recurrent events with an associated terminal event
    Gerrit Toenges, Antje Jahn‐Eimermacher · 2019 · Computer Methods and Programs in Biomedicine
23. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
    Robert John Mentz, Amanda Stebbins, Javed Butler, Chern‐En Chiang, Justin Adrian Ezekowitz, Adrian F. Hernandez, Robert J. Hilkert, Carolyn S.P. Lam, Kenneth McDonald, Christopher M. O’Connor et al. · 2024 · JACC Heart Failure
24. Predictive Value of Pro-BNP for Heart Failure Readmission after an Acute Coronary Syndrome
    Alberto Cordero, Elías Martínez Rey-Rañal, Maria José Carvalho Moreno, David Escribano, José Moreno Arribas, María Amparo Quintanilla, Pilar Zuazola, Julio E. Núñez, Vicente Bertomeu‐González · 2021 · Journal of Clinical Medicine
25. A studentized permutation test for three‐arm trials in the ‘gold standard’ design
    Tobias Mütze, Frank Konietschke, Axel Munk, Tim Friede · 2016 · Statistics in Medicine
26. Impact of Cardiac Resynchronization Therapy on Hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial
    Anne M. Gillis, Charles R. Kerr, François Philippon, Gary E. Newton, Mario R. Talajic, Michael P.V. Froeschl, Sandra Froeschl, Elizabeth Swiggum, Elizabeth Yetisir, George A. Wells et al. · 2014 · Circulation
27. Serum neprilysin and recurrent hospitalizations after acute heart failure
    Julio E. Núñez, Eduardo Núñez, Gema Miñana, Arturo Carratalá, Juan Manuel Sanchís, Josep Lupón, Jaume Barallat, M.C. Pastor, Domingo Andrés Pascual-Figal, Antoni Bayés‐Genís · 2016 · International Journal of Cardiology
28. Disease Management plus Recommended Care versus Recommended Care Alone for Ambulatory Patients with Chronic Obstructive Pulmonary Disease
    Ofra Kalter‐Leibovici, Michal Benderly, Laurence S. Freedman, Galit Kaufman, Tchiya Molcho, Havi Murad, Liraz Olmer, Meri Gluch, David Segev, Avi Gilad et al. · 2018 · American Journal of Respiratory and Critical Care Medicine
29. Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!
    Nicolas Girerd, Faiez M. Zannad, Patrick Rossignol · 2015 · Diabetes & Metabolism
30. The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development
    Michael H. Davidson, Andrew Hsieh, Mary R. Dicklin, Kevin Carl Maki · 2024 · JACC Basic to Translational Science
31. Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients
    Jennifer Kaye Rogers, Adrian Kielhorn, JEFFREY S. BORER, Ian Ford, Stuart Pocock · 2015 · Current Medical Research and Opinion
32. Adaptive treatment allocation for comparative clinical studies with recurrent events data
    Jingya Gao, Pei‐Fang Su, Feifang Hu, Siu Hung Cheung · 2019 · Biometrics
33. Early and recurrent hospitalization after kidney transplantation: Analysis of a contemporary canadian cohort of kidney transplant recipients
    Joel C. Bergman, Karthik Tennankore, Amanda Jean Vinson · 2020 · Clinical Transplantation
34. What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
    Kaja Sevre, Aurora Rist, Kristian Wachtell, Richard B. Devereux, Gerard P. Aurigemma, Otto Armin Smiseth, Sverre Erik Kjeldsen, Stevo Julius, Bertram Pitt, Michel Burnier et al. · 2023 · American Journal of Hypertension
35. Predictors of Need for First and Recurrent Emergency Medical Service Transport to Emergency Department after Dialysis Initiation
    Amanda Jean Vinson, John Bartolacci, Judah Goldstein, Janel Swain, David A. Clark, Karthik Tennankore · 2019 · Prehospital Emergency Care
36. A studentized permutation test for three-arm trials in the 'gold standard' design.
    Mütze, T., Frank Konietschke, Axel Munk, Tim Friede · 2017 · Max Planck Digital Library
37. Nonparametric Inference of General While-Alive Estimands for Recurrent Events
    Lu Mao · 2022 · Biometrics
38. Cardiac neuronal imaging with 123I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions
    Mario Petretta, Teresa Pellegrino, Alberto Cuocolo · 2014 · European Journal of Nuclear Medicine and Molecular Imaging
39. Impacto pronóstico a largo plazo de la anticoagulación en pacientes en hemodiálisis con fibrilación auricular
    Ruth María Sánchez Soriano, María Dolores Albero Molina, Carlos Israel Chamorro Fernández, Rocío Juliá‐Sanchis, Ramón López-Menchero, Carlos del Pozo Fernández, Guillermo Grau Jornet, Julio Núñez Villota · 2018 · Nefrología
40. Life history analysis with multistate models: A review and some current issues
    Richard J. Cook, Jerald F. Lawless · 2022 · Canadian Journal of Statistics
41. A deep learning approach to censored regression
    Vlad-Rareş Dănăilă, Cătălin Buiu · 2024 · Pattern Analysis and Applications
42. Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)
    Sean Virani, Shelley R. Zieroth, Natasha Aleksova, Kim Anderson, Brian Clarke, Anique Ducharme, Justin Adrian Ezekowitz, Farid Foroutan, Nadia Giannetti, Rahul Jain et al. · 2025 · Canadian Journal of Cardiology · Retracted
43. Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality
    Ryan Field, Carly Adamson, Pardeep S. Jhund, Jim Lewsey · 2023 · BMC Medical Research Methodology
44. Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trial
    Christian Jøns, Poul Erik Bloch Thomsen, Sam Riahi, Tom Smilde, Ulrich Bach, Peter Karl Jacobsen, Miloš Táborský, József Faluközy, Marcus Wiemer, Per Dahl Christensen et al. · 2024 · Frontiers in Cardiovascular Medicine
45. Troponina T de alta sensibilidad y riesgo de hospitalizaciones recurrentes tras un ingreso por insuficiencia cardíaca aguda
    D. Escribano, Enrique Santas, Gema Miñana, Anna Mollar, Sergio García‐Blas, Ernesto Valero, Ana Payá, F. Javier Chorro, Juan Manuel Sanchís, Julio E. Núñez · 2016 · Revista Clínica Española
46. High-sensitivity troponin T and the risk of recurrent readmissions after hospitalization for acute heart failure
    D. Escribano, Enrique Santas, Gema Miñana, Anna Mollar, Sergio García‐Blas, Ernesto Valero, Ana Payá, F. Javier Chorro, Juan Manuel Sanchís, Julio E. Núñez · 2017 · Revista Clínica Española (English Edition)
47. Sleep apnea and recurrent heart failure hospitalizations after coronary artery bypass grafting
    Yao Hao Teo, Wilson Tam, Chieh Yang Koo, Aye-Thandar Aung, Ching‐Hui Sia, Raymond Ching-Chiew Wong, William K F Kong, Kian Keong Poh, Theo Kofidis, Pipin Kojodjojo et al. · 2021 · Journal of Clinical Sleep Medicine
48. A joint frailty model provides for risk stratification of human immunodeficiency virus–infected patients based on unobserved heterogeneity
    Tae Hyun Jung, Tassos C. Kyriakides, Mark Holodniy, Denise Ann Esserman, Peter N. Peduzzi · 2018 · Journal of Clinical Epidemiology
49. Targeting the Vulnerable Phase of Heart Failure: Initiate Novel Therapies in Stable Patients Prior to Hospitalization
    Muthiah Vaduganathan, Ravi B. Patel, Stephen John Greene, Mihai Gheorghiade · 2016 · European Journal of Heart Failure
50. Value of Digoxin in Patients with Heart Failure: New Pieces to the Puzzle
    Dirk Jan van Veldhuisen, Michiel Rienstra, Peter van der Meer · 2018 · European Journal of Heart Failure
51. Frailty modelling for multitype recurrent events in clinical trials
    Paul M. Brown, Justin Adrian Ezekowitz · 2018 · Statistical Modelling
52. Group sequential designs with robust semiparametric recurrent event models
    Tobias Mütze, Ekkehard Glimm, Heinz Schmidli, Tim Friede · 2018 · Statistical Methods in Medical Research
53. Assessing Treatment Effects That Capture Disease Burden in Serious Chronic Diseases
    Mouna Akacha, Bruce S. Binkowitz, Brian Lee Claggett, Hung Hung, Guenther Mueller‐Velten, Norman Stockbridge · 2018 · Therapeutic Innovation & Regulatory Science
54. Espironolactona en pacientes con insuficiencia cardiaca y fracción de eyección preservada
    Julio E. Núñez, Eduardo Núñez, Juan Manuel Sanchís · 2015 · Revista Clínica Española
55. Win Ratio -An Intuitive and Easy-To-Interpret Composite Outcome in Medical Studies.
    Hongyue Wang, Jing Peng, Juila Z Zheng, Bokai Wang, Xiang Lu, Chongshu Chen, Xin Ming Tu, Changyong Feng · 2017 · PubMed Central
56. Rationale and Design of PURE: A Randomized Controlled Trial to Evaluate Peritoneal Ultrafiltration with PolyCore™ in Refractory Congestive Heart Failure
    Edoardo Gronda, Maurizio Alberto Gallieni, Giuseppe Pacileo, Giovambattista Capasso, Lee‐Jen Wei, Francesco Trepiccione, Marco Heidempergher, Mario Bonomini, Marco Zimarino, José Carolino Divino‐Filho et al. · 2024 · Kidney & Blood Pressure Research
57. Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
    Tamar I. de Vries, Jan Westerink, Michiel L. Bots, Folkert Wouter Asselbergs, Yvo Michiel Smulders, Frank L.J. Visseren · 2021 · BMJ Open
58. Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
    Andrew V. Xanthopoulos, Angeliki Bourazana, Yuya Matsue, Yudai Fujimoto, Shogo Oishi, Eiichi Akiyama, Satoshi Suzuki, Masayoshi Yamamoto, Keisuke Kida, Takahiro Okumura et al. · 2023 · Journal of Clinical Medicine
59. Sacubitril/Valsartan Compared to Ramipril in High-Risk Post-Myocardial Infarction Patients Stratified According to Use of Mineralocorticoid Receptor Antagonists: Insight from the PARADISE MI Trial
    Morten Schou, Brian Lee Claggett, Zi Michael Miao, Alberto Fernández, Gerasimos S Filippatos, Christopher Bull Granger, Karola Jering, Aldo Pietro Maggioni, Finnian R. Mc Causland, Julio Nuñez Villota et al. · 2023 · European Journal of Heart Failure
60. Effects of Canagliflozin on Total Heart Failure Events Across the Kidney Function Spectrum: Participant-Level Pooled Analysis from the CANVAS Program and CREDENCE Trial
    Muthiah Vaduganathan, Christopher Paul Cannon, Meg Jardine, Hiddo J.L. Heerspink, Clare Gabrielle Arnott, Brendon Lange Neuen, Ashish Sarraju, Jagadish P. Gogate, Jochen Seufert, Bruce Charles Neal et al. · 2024 · European Journal of Heart Failure
61. Treatment with renin‐angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity‐matched study in the community
    Puente Egido Jj, Rocio Gomez, Sotero P. Romero, José L. Andrey, Daniel Ramirez, Ana Rodriguez, Maria J. Pedrosa, Francisco Gomez · 2019 · International Journal of Clinical Practice
62. Response-adaptive treatment randomization for multiple comparisons of treatments with recurrent event responses
    Jingya Gao, Feifang Hu, Siu Hung Cheung, Pei‐Fang Su · 2022 · Statistical Methods in Medical Research
63. First and recurrent events after percutaneous coronary intervention: implications for survival analyses
    Anupama Vasudevan, James W. Choi, Georges A. Feghali, Aaron Y. Kluger, Stuart R. Lander, Kristen M. Tecson, Mohanakrishnan Sathyamoorthy, JEFFREY M. SCHUSSLER, Robert Stoler, Ravi C. Vallabhan et al. · 2019 · Scandinavian Cardiovascular Journal
64. Power and Sample Size Calculations for the Restricted Mean Time Analysis of Prioritized Composite Endpoints
    Lu Mao · 2022 · Statistics in Biopharmaceutical Research
65. Marginal hazard ratio estimates in joint frailty models for heart failure trials
    Gerrit Toenges, Antje Jahn‐Eimermacher · 2019 · Biometrical Journal
66. Early Midterm Results After Valve Replacement With Contemporary Pericardial Prostheses for Severe Aortic Stenosis
    Fraser Douglas Rubens, Janet M.C. Ngu, Anahita Malvea, Steven J. Samuels, Ian G. Burwash · 2020 · The Annals of Thoracic Surgery
67. Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal <70 mg/dL: a real-life cohort in a developing country
    Arintaya Phrommintikul, Surarong Chinwong, Jayanton Patumanond, Dujrudee Chinwong, John Joseph Hall · 2016 · Therapeutics and Clinical Risk Management
68. Vitamin D deficiency can impair respiratory health
    Bruce L. Davidson, Khalid Alansari · 2018 · Respirology
69. Long-term outcomes among stable post-acute myocardial infarction patients living in rural versus urban areas: insights from the prospective, observational TIGRIS registry
    José Carlos Nicolau, Ruth Owen, Remo H.M. Furtado, Shaun G. Goodman, Christopher Bull Granger, Mauricio G. Cohen, Dirk Westermann, Satoshi Yasuda, Tabassome Simon, Katarina Hedman et al. · 2023 · Open Heart
70. Generalised pairwise comparisons for trend: An extension to the win ratio and win odds for dose-response and prognostic variable analysis with arbitrary statements of outcome preference
    Hannah Tabitha Johns, Bruce C.V. Campbell, Julie A Bernhardt, Leonid P. Churilov · 2022 · Statistical Methods in Medical Research
71. Comparison of nonparametric estimators of the expected number of recurrent events
    Alexandra Erdmann, Jan Beyersmann, Erich Bluhmki · 2023 · Pharmaceutical Statistics
72. Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation
    Brian A. Bergmark, Jeong‐Gun Park, Rose A. Hamershock, Giorgio E. M. Melloni, Raffaele De Caterina, Elliott Marshall Antman, Christian Thomas Ruff, Howard Rutman, Michele F. Mercuri, Hans‐Joachim Lanz et al. · 2024 · Circulation Cardiovascular Quality and Outcomes
73. A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
    Gerrit Toenges, Tobias Mütze, Antje Jahn‐Eimermacher · 2021 · Statistics in Medicine
74. Multitype Events and the Analysis of Heart Failure Readmissions
    Paul M. Brown, Justin Adrian Ezekowitz · 2017 · Circulation Cardiovascular Quality and Outcomes
75. Long-term prognostic impact of anticoagulation on patients with atrial fibrillation undergoing hemodialysis
    Ruth María Sánchez Soriano, María Dolores Albero Molina, Carlos Israel Chamorro Fernández, Rocío Juliá‐Sanchis, Ramón López-Menchero, Carlos del Pozo Fernández, Guillermo Grau Jornet, Julio Núñez Villota · 2018 · Nefrología (English Edition)
76. Primary care-based integrated disease management for heart failure: a study protocol for a cluster randomised controlled trial
    Anna Hussey, Robert Samuel McKelvie, Madonna Ferrone, Teresa M. To, Melissa Fisk, Dhssraj Singh, Cathy Faulds, Christopher J. Licskai · 2022 · BMJ Open
77. Addition of Antiangina Drugs and Recurrent Cardiovascular Events Associated With Incomplete Revascularization in Acute Coronary Syndrome
    Alberto Cordero, Ramón López‐Palop, Pilar Carrillo, Araceli Frutos, Vicente Bertoméu · 2017 · Revista Española de Cardiología (English Edition)
78. Reply to K. Yokoyama et al
    Christopher W. Noel, Rinku Sutradhar, Haoyu Zhao, Victoria Delibasic, David W.A. Forner, Jonathan Crawford Irish, John Kim, Zain Ali Husain, Alyson L Mahar, Irene Karam et al. · 2021 · Journal of Clinical Oncology
79. Study Design for Restricted Mean Time Analysis of Recurrent Events and Death
    Lu Mao · 2023 · Biometrics
80. Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD
    Shea Elizabeth Hogan, Michael J. Szarek, E. Sebastian Debus, Mark R. Nehler, Sonia Savitri Anand, Manesh R. Patel, Akos Ferenc Pap, Hsiaowei Deng, Sophie Hodge, Lloyd Peter Haskell et al. · 2025 · Journal of the American Heart Association
81. Geographical Variations in Patients with Heart Failure and Preserved Ejection Fraction: A Sub-Group Analysis of the APOLLON Registry
    Bülent Özlek, Eda Özlek, Hicaz Zencirkıran Ağuş, Mehmet Tekinalp, Serkan Kahraman, Oğuzhan Çelik, Cem Çil, Özcan Başaran, Volkan Doğan, Bedri Caner Kaya et al. · 2019 · Balkan Medical Journal
82. First and recurrent events in the ISCHEMIA trial: two sides of the same coin
    Davide Cao, Carl J. Pepine, Roxana Mehran · 2021 · European Heart Journal
83. Comparison of Time-to-First-Event and Recurrent Event Methods in Multiple Sclerosis Trials
    Alexandra Bühler · 2021 · arXiv (Cornell University)
84. Clustered observations
    Leonard Leibovici · 2018 · Clinical Microbiology and Infection
85. The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial
    Kunihiko Matsui, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura et al. · 2022 · BMC Medicine
86. The risk of repeated suicidal presentations following residential treatment for substance use disorders: A recurrent event analysis using linked administrative data
    Calvert Tisdale, Dominique de Andrade, Janni Leung, Gabrielle Campbell, Leanne M. Hides · 2024 · Journal of Affective Disorders
87. Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study
    José Carlos Nicolau, Sabina A. Murphy, Robert Patrick Giugliano, Lawrence A. Leiter, Gaetano Maria De Ferrari, Jeong‐Gun Park, Julia Kuder, Lyrica Liu, Huei Wang, Vineet Shastri-Kumar et al. · 2026 · Journal of the American College of Cardiology
88. Estimation of a recurrent event gap time distribution: an application to morbidity outcomes following lower extremity fracture in Veterans with spinal cord injury
    Lauren Bailey, Frances M. Weaver, Amy S. Chin, Laura D. Carbone · 2014 · Health Services and Outcomes Research Methodology
89. Publishing in a Heart Failure Journal—Where Lies the Scientific Interest?
    Amir Emami, Nicole Ebner, Stephan von Haehling · 2017 · ESC Heart Failure
90. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency
    Piotr P. Ponikowski, Dirk Jan van Veldhuisen, Josep Comin Colet, Georg Ertl, Michel Komajda N, Viacheslav Mareev, Theresa A. McDonagh, Alexander N. Parkhomenko, Luigi Tavazzi, Victoria Levesque et al. · 2014 · ESC Heart Failure
91. Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study
    Sayaka Shimizu, Kakuya Niihata, Hiroki Nishiwaki, Yugo Shibagaki, Ryohei Yamamoto, Kosaku Nitta, Tatsuo Tsukamoto, Shunya Uchida, Asami Takeda, Hirokazu Okada et al. · 2023 · Clinical and Experimental Nephrology
92. Adición de antianginosos y complicaciones cardiovasculares recurrentes asociadas a la revascularización incompleta en el síndrome coronario agudo
    Alberto Cordero, Ramón López‐Palop, Pilar Carrillo, Araceli Frutos, Vicente Bertoméu · 2017 · Revista Española de Cardiología
93. Influence of standard heart failure therapy on readmission rate: opportunities and limitations in modern clinical practice
    Sergey R. Gilyarevsky · 2021 · Russian Journal of Cardiology
94. Optimal decongestive therapy in acute decompensated heart failure syndromes: Far from being solved
    Julio E. Núñez, Eduardo Núñez, Vicent Bodı́, Antoni Bayés‐Genís, Juan Manuel Sanchís · 2014 · International Journal of Cardiology
95. Initiation of Renin-Angiotensin System Inhibitors and the Incidence of First Complete Remission in Patients with Primary Nephrotic Syndrome: A Nationwide Cohort Study
    Sayaka Shimizu, Kakuya Niihata, Hiroki Nishiwaki, Yugo Shibagaki, Ryohei Yamamoto, Kosaku Nitta, Tatsuo Tsukamoto, Shunya Uchida, Asami Takeda, Hirokazu Okada et al. · 2022 · Research Square
96. Predicting treatment response in patients with HFpEF and myocardial fibrosis. Identifying useful tools with the help of CMR
    Lukas Stoiber, Alexandros Kasiakogias · 2022 · The International Journal of Cardiovascular Imaging
97. Novel insights into heart failure with preserved ejection fraction
    Carolyn S.P. Lam · 2016 · University of Groningen research database (University of Groningen / Centre for Information Technology)
98. Multiple Outcomes in Heart Failure Research: Composite Endpoints and Multivariate Modelling
    Paul M. Brown · 2017 · ERA: Education and Research Archive (University of Alberta)
99. Vive les Differences!—A case for optimism in the treatment of patients with heart failure and preserved ejection fraction?
    Jonathan P. Law, Luke C. Pickup, John Townend, Charles Joseph Ferro · 2018 · International Journal of Clinical Practice
100. Adaptive designs for clinical trials in cardiovascular diseases
     Tobias Mütze · 2018